Thrombosis and Thrombophilia in Children: A Systematic Review

Daniela Tormene; Sabrina Gavasso; Valeria Rossetto; Paolo Simioni

doi:10.1055/s-2006-951457

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2006; 32(7): 724-728
DOI: 10.1055/s-2006-951457

Thrombosis and Thrombophilia in Children: A Systematic Review

Daniela Tormene¹ , Sabrina Gavasso¹ , Valeria Rossetto¹ , Paolo Simioni¹

¹Department of Medical and Surgical Sciences, University of Padua Medical School, Padua, Italy

Abstract

ABSTRACT

Thrombotic events are uncommon disorders in childhood but increasingly recognized due to the progress made in the understanding of the hemostasis system and the importance of thromboembolic disorders in children. Multiple clinical underlying conditions and prothrombotic disorders contribute to the development of thrombosis in neonates and children. In recent years programs have emerged that specialize in the diagnosis, prevention, and treatment of thrombosis in children. This review summarizes the current knowledge of the risk factors for thromboembolic events in the venous and arterial systems in children, the use of antithrombotic prophylaxis, and the role of thrombophilia. First, the clinical manifestations and the problems of diagnosing venous thromboembolic diseases and cerebrovascular diseases in children are reviewed. The prophylactic use of anticoagulants in children is also discussed. Unfortunately there are no large prospective randomized trials in children, thus guidelines are based on small studies or on extrapolation of data from adults. Second, the impact of prothrombotic defects in pediatric patients and the issue of routine testing for these disturbances are reviewed.

KEYWORDS

Thrombosis - children - risk factors - thrombophilia

Full Text

References

REFERENCES

1 Andrew M, David M, Adams M et al.. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994; 83 1251-1257
2 Monagle P, Adams M, Mahoney M et al.. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000; 47 763-766
3 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995; 96 939-943
4 Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997; 76 F163-167
5 Massicotte M P, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter-related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr. 1998; 133 770-776
6 The PIOPED Investigators . Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis. JAMA. 1990; 263 2753-2759
7 The PISA-PED Investigators . Invasive and non-invasive diagnosis of pulmonary embolism. Preliminary results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis. Chest. 1995; 107 33S-38S
8 Monagle P, Peters M, Andrew M. Pulmonary embolism in childhood. In: van Beek E, Oudkerk M, ten Cate JW Pulmonary Embolism: Epidemiology, Diagnosis, and Treatment. Oxford, UK; Blackwell Scientific Publishers 1998
9 Male C, Chait P, Ginsberg J S et al.. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost. 2002; 87 593-598
10 Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odievre M, Alagille D. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr. 1983; 103 696-702
11 van Ommen C H, Heijboer H, Büller H R, Hirasing R A, Heijmans H S, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr. 2001; 139 676-681
12 Prandoni P, Polistena P, Bernardi E et al.. Upper extremity deep vein thrombosis. Risk factors, diagnosis and complications. Arch Intern Med. 1997; 157 57-62
13 Elliot G. Upper extremity deep vein thrombosis. Lancet. 1997; 349 1188-1189
14 Hibbert J, Howlett C, Greenwood K L, MacDonald L M, Saunders A J. The ultrasound appearances of neonatal renal vein thrombosis. Br J Radiol. 1997; 70 1191-1194
15 Massicotte P, Julian J A, Gent M. et al PROTEKT Study Group . An open- label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res. 2003; 109 101-108
16 Kuhle S, Koloshuk B, Marzinotto V et al.. A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res. 2003; 111 227-233
17 Freed M D, Keane J F, Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation. 1974; 50 565-569
18 Monagle P, Michelson A D, Bovill E, Andrew M. Antithrombotic therapy in children. Chest. 2001; 119 344S-370S
19 Schoenberg B S, Mellinger J F, Schoenberg D G. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978; 28 763-768
20 Gabrielle A, de Veber G A, Adams M, Andrew M. and the Canadian Pediatric Neurologists. Canadian pediatric ischemic stroke registry. Analysis III. Thromb Haemost. 1995; 73 1400 (abst)
21 deVeber G A, Adams M, Andrew M. Cerebral thromboembolism in neonates: clinical and radiographic features. Thromb Haemost. 1997; 78(suppl) 725 (abst)
22 Hoggard N, Wilkinson I D, Griffiths P D. The imaging of ischaemic stroke. Clin Radiol. 2001; 56 171-183
23 Ganesan V, Savvy L, Chong W K, Kirkham F J. Conventional cerebral angiography in children with ischemic stroke. Pediatr Neurol. 1999; 20 38-42
24 Husson B, Rodesch G, Lasjaunias P, Tardieu M, Sebire G. Magnetic resonance angiography in childhood arterial brain infarcts: a comparative study with contrast angiography. Stroke. 2002; 33 1280-1285
25 Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology. 2000; 54 371-378
26 Isler W. Stroke in childhood and adolescence. Eur Neurol. 1984; 23 421-424
27 deVeber G, Andrew M. Canadian pediatric ischemic stroke registry. Analysis. Pediatr Res. 1994; 35 379A (abst)
28 Lanska M J, Lanska D J, Horwitz S J, Aram D M. Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol. 1991; 7 333-341
29 deVeber G, Andrew M, Adams C. et al Canadian Pediatric Ischemic Stroke Study Group . Cerebral sinovenous thrombosis in children. N Engl J Med. 2001; 345 417-423
30 Zimmerman R A, Bogdan A R, Gusnard D A. Pediatric magnetic resonance angiography: assessment of stroke. Cardiovasc Intervent Radiol. 1992; 15 60-64
31 Medlock M D, Olivero W C, Hanigan W C, Wright R M, Winek S J. Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography. Neurosurgery. 1992; 31 870-876
32 Bezinque S L, Slovis T L, Touchette A S et al.. Characterization of superior sagittal sinus blood flow velocity using color flow Doppler in neonates and infants. Pediatr Radiol. 1995; 25 175-179
33 Hagstrom J N, Walter J, Bluebond-Langner R, Amatniek J C, Manno C S, High K A. Prevalence of the factor V leiden mutation in children and neonates with thromboembolic disease. J Pediatr. 1998; 133 777-781
34 Lawson S E, Butler D, Enayat M S, Williams M D. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child. 1999; 81 176-178
35 Ehrenforth S, Junker R, Koch H G et al.. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. Eur J Pediatr. 1999; 158 S97-104
36 Junker R, Koch H G, Auberger K, Munchow N, Ehrenforth S, Nowak-Göttl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol. 1999; 19 2568-2572
37 Bonduel M, Hepner M, Sciuccati G, Torres A F, Pieroni G, Frontroth J P. Prothrombotic abnormalities in children with venous thromboembolism. J Pediatr Hematol Oncol. 2000; 22 66-72
38 Kosch A, Junker R, Kurnik K et al.. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res. 2000; 99 531-537
39 van Ommen C H, Heijboer H, van den Dool E J, Hutten B A, Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost. 2003; 1 2516-2522
40 Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thrombpoembolism disease. J Thromb Haemost. 2003; 1 915-921
41 Bonduel M, Hepner M, Sciuccati G et al.. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb Haemost. 2002; 87 972-977
42 Nowak-Göttl U, Junker R, Kreuz W Childhood Thrombophilia Study Group et al.. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001; 97 858-862
43 Goldenberg N A, Knapp-Clevenger R, Manco-Johnson M J. and the Mountain States Regional Thrombophilia Group . Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med. 2004; 351 1081-1088
44 Tormene D, Simioni P, Prandoni P et al.. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood. 2002; 100 2403-2405
45 deVeber G, Monagle P, Chan A et al.. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol. 1998; 55 1539-1543
46 Junker R, Strater R. and the Childhood Stroke Study Group . Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke. 2000; 31 2437-2441
47 Kenet G, Sadetzki S, Murad H et al.. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000; 31 1283-1288
48 Nowak-Göttl U, Strater R, Heinecke A et al.. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999; 94 3678-3682
49 Kurnik K, Kosch A, Strater R, Schobess R, Heller C, Nowak-Göttl U. Childhood Stroke Study Group . Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke. 2003; 34 2887-2892
50 Kenet G, Waldman D, Lubetsky A et al.. Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. Thromb Haemost. 2004; 92 713-718

Daniela TormeneM.D.

Department of Medical and Surgical Sciences, 2nd Chair of Internal Medicine

via Ospedale 105, 35128 Padua, Italy

Email: daniela.tormene@unipd.it